tiprankstipranks
Trending News
More News >
Hepion Pharmaceuticals (HEPA)
OTHER OTC:HEPA
US Market

Hepion Pharmaceuticals (HEPA) Income Statement

Compare
790 Followers

Hepion Pharmaceuticals Income Statement

Last quarter (Q3 2025), Hepion Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Hepion Pharmaceuticals's net income was $-472.51K. See Hepion Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 19.35M$ 48.45M$ 45.49M$ 30.40M$ 20.15M
Depreciation and Amortization
$ 30.76K$ 67.13K$ 77.46K$ 86.07K$ 34.52K
EBITDA
$ -14.88M$ -49.26M$ -45.00M$ -32.63M$ -20.11M
Operating Income
$ -19.35M$ -48.45M$ -45.49M$ -30.40M$ -20.15M
Other Income/Expenses
$ 3.18M$ -887.11K$ 404.83K$ -2.32M$ -177.28K
Pretax Income
$ -16.16M$ -49.34M$ -45.08M$ -32.72M$ -20.32M
Net Income
$ -13.19M$ -48.93M$ -42.20M$ -32.72M$ -20.35M
Per Share Metrics
Basic EPS
$ -107.35$ -616.07$ -594.75$ -465.52$ -2.10K
Diluted EPS
$ -107.35$ -616.07$ -594.75$ -465.52$ -2.10K
Weighted Average Shares Outstanding
122.89K 79.42K 76.23K 70.29K 9.68K
Weighted Average Shares Outstanding (Diluted)
122.89K 79.42K 76.23K 70.29K 9.68K
Currency in USD

Hepion Pharmaceuticals Earnings and Revenue History